Squarepoint’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,179
Closed -$539K 4785
2023
Q4
$539K Sell
18,179
-317,911
-95% -$6.33M ﹤0.01% 2955
2023
Q3
$5.33M Buy
336,090
+260,714
+346% +$4.34M 0.01% 1135
2023
Q2
$1.42M Buy
+75,376
New +$890K ﹤0.01% 1910
2023
Q1
Sell
-243,195
Closed -$1.21M 3961
2022
Q4
$1.21M Sell
243,195
-106,815
-31% -$579K ﹤0.01% 1697
2022
Q3
$1.67M Buy
350,010
+233,781
+201% +$1.23M 0.01% 1435
2022
Q2
$523K Sell
116,229
-140,721
-55% -$611K ﹤0.01% 1992
2022
Q1
$1.22M Buy
256,950
+195,742
+320% +$1.08M 0.01% 1462
2021
Q4
$454K Sell
61,208
-6,386
-9% -$39.7K ﹤0.01% 2198
2021
Q3
$383K Sell
67,594
-50,876
-43% -$294K ﹤0.01% 2118
2021
Q2
$781K Sell
118,470
-155,056
-57% -$1.08M ﹤0.01% 1816
2021
Q1
$2.22M Buy
273,526
+61,338
+29% +$501K 0.01% 1009
2020
Q4
$1.37M Buy
212,188
+115,405
+119% +$673K 0.01% 1147
2020
Q3
$348K Buy
96,783
+62,475
+182% +$252K ﹤0.01% 1696
2020
Q2
$158K Sell
34,308
-8,610
-20% -$36.6K ﹤0.01% 1899
2020
Q1
$146K Sell
42,918
-242,637
-85% -$1.06M ﹤0.01% 1563
2019
Q4
$1.46M Sell
285,555
-316,271
-53% -$1.07M 0.01% 1092
2019
Q3
$1.46M Buy
601,826
+559,035
+1,306% +$1.48M 0.01% 987
2019
Q2
$93K Sell
42,791
-259,390
-86% -$613K ﹤0.01% 2236
2019
Q1
$819K Buy
302,181
+13,125
+5% +$56.9K 0.01% 1198
2018
Q4
$1.39M Buy
289,056
+199,356
+222% +$1.21M 0.02% 808
2018
Q3
$849K Sell
89,700
-1,100
-1% -$10.6K 0.01% 1070
2018
Q2
$883K Buy
90,800
+49,600
+120% +$523K 0.01% 938
2018
Q1
$433K Buy
+41,200
New +$407K 0.01% 1146
2017
Q1
Sell
-75,083
Closed -$153K 1986
2016
Q4
$153K Buy
+75,083
New +$151K 0.01% 1536
2016
Q1
Sell
-24,100
Closed -$327K 1506
2015
Q4
$327K Buy
+24,100
New +$297K 0.04% 760

Other funds holding IMGN

Squarepoint's IMGN Position: Q1 2024 in Review

Squarepoint sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 18,179 shares — an estimated $539K sold.

Squarepoint first reported a position in IMGN in Q4 2015 and held it in 25 quarters. The position peaked at $5.33M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Squarepoint reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Squarepoint sold 18,179 Immunogen Inc shares in Q1 2024, an estimated $539K.
  • Squarepoint first reported a position in Immunogen Inc in Q4 2015 and held it in 25 quarters.
  • Squarepoint's Immunogen Inc position peaked at $5.33M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.